In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. November 17, 2021

    Ohio Counties Deride Pharmacies' Opioid Mistrial Bid

    Ohio counties awaiting a verdict in their opioid-crisis case against three major pharmacy chains asked a Cleveland federal judge Wednesday to reject the defendants' bid for a mistrial based on closing arguments, saying the proposed remedy would be far too "drastic."

  2. November 16, 2021

    Pharmacies Urge Mistrial In Opioid Case As Jury Deliberates

    Only a mistrial can fix "egregious" closing arguments in a case shortly expected to yield the first jury verdict in opioid-crisis litigation, three major pharmacy chains told a Cleveland federal judge Tuesday.

  3. November 15, 2021

    Lax Pharmacies Fed Opioid Crisis, Jury Told As Trial Ends

    The first trial over pharmacies' role in the opioid epidemic wrapped up Monday as a Cleveland jury heard claims that three major chains failed to use their unique position and data to block problem prescriptions, irresponsibly handing off drugs that "grab you by the throat."

  4. October 29, 2021

    Endo, Arnold & Porter Split Amid Opioid Litigation Troubles

    Amid a major controversy over discovery shortcomings, Endo Pharmaceuticals disclosed late Friday that Arnold & Porter is departing as its counsel in multidistrict opioid litigation and being replaced by Skadden.

  5. October 27, 2021

    Giant Eagle Strikes Deal To Leave Ohio Opioid Bellwether

    Pharmacy chain Giant Eagle on Wednesday said it had reached a settlement to end allegations that its opioid practices contributed to a public nuisance in two Ohio counties and to leave the first-ever federal jury trial against pharmacies in the opioid litigation, according to sources familiar with the matter.

  6. October 26, 2021

    Skadden Strives To Tame Flames In Endo's Opioid Imbroglio

    Scorched by cover-up claims in nationwide opioid litigation, Endo Pharmaceuticals is hoping for heroics from a Skadden squad that is belatedly revealing vast volumes of drug marketing records, a strategy that could simultaneously snuff out some discovery deficiencies and fuel new doubts about the drugmaker's initial transparency.

  7. October 25, 2021

    Opioid Expert's Addiction Calculations Off Base, Jury Hears

    Jurors weighing a New York opioid case heard Monday from one of the final live defense witnesses in the long-running trial, a psychiatrist who worked to discredit earlier testimony by a Stanford doctor about rates of opioid addiction.

  8. October 25, 2021

    Pharmacies' Mistrial Bid Shot Down In Opioid Bellwether

    The Ohio federal judge presiding over the bellwether opioid trial brought by two Ohio counties against pharmacies on Monday denied the defendants' bid for a mistrial, which they had sought on the grounds that a juror conducted her own research in defiance of the court's orders.

  9. October 19, 2021

    Teva Fears 'Incredibly Damaging' Parody Videos In Opioid Trial

    Teva Pharmaceuticals is scrambling to stop jurors in a New York opioid trial from viewing internal videos that transformed famous film scenes into parodies of narcotic painkiller marketing, warning that the clips are so provocative they could single-handedly destroy the drugmaker's defense.

  10. October 18, 2021

    Walmart Blasts Ohio Counties' Sanctions Bid In Opioid Trial

    Walmart on Monday told the Ohio federal judge overseeing two counties' bellwether trial against pharmacies in the opioid multidistrict litigation that their request for sanctions is "ginned up" and based on documents already produced that have nothing to do with the counties.